share_log

Ziegler Capital Management LLC Grows Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI)

Ziegler Capital Management LLC Grows Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI)

齐格勒资本管理公司增持默里特医疗系统公司(纳斯达克代码:MMSI)
Financial News Live ·  2023/01/02 09:41

Ziegler Capital Management LLC lifted its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating) by 0.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 201,908 shares of the medical instruments supplier's stock after buying an additional 1,816 shares during the quarter. Ziegler Capital Management LLC owned approximately 0.36% of Merit Medical Systems worth $11,410,000 at the end of the most recent quarter.

Ziegler Capital Management LLC在最近一次向美国证券交易委员会(SEC)披露的信息中称,该公司第三季度将其在纳斯达克(Sequoia Capital Systems,Inc.)股票的持仓量上调了0.9%。该机构投资者在本季度额外购买了1,816股后,持有这家医疗器械供应商的201,908股票。截至最近一个季度末,Ziegler Capital Management LLC拥有Merit Medical Systems约0.36%的股份,价值11,410,000美元。

A number of other institutional investors have also modified their holdings of MMSI. Lindbrook Capital LLC grew its stake in Merit Medical Systems by 148.4% in the 2nd quarter. Lindbrook Capital LLC now owns 477 shares of the medical instruments supplier's stock worth $26,000 after acquiring an additional 285 shares during the period. Harel Insurance Investments & Financial Services Ltd. purchased a new stake in shares of Merit Medical Systems in the second quarter valued at $37,000. Quantbot Technologies LP acquired a new position in Merit Medical Systems in the first quarter valued at $43,000. First Horizon Advisors Inc. lifted its position in Merit Medical Systems by 56.2% during the second quarter. First Horizon Advisors Inc. now owns 1,287 shares of the medical instruments supplier's stock worth $70,000 after buying an additional 463 shares during the period. Finally, Eagle Bay Advisors LLC boosted its stake in Merit Medical Systems by 87.0% in the 2nd quarter. Eagle Bay Advisors LLC now owns 1,870 shares of the medical instruments supplier's stock worth $101,000 after buying an additional 870 shares during the last quarter. Institutional investors and hedge funds own 95.38% of the company's stock.

其他一些机构投资者也调整了对MMSI的持股。林德布鲁克资本有限责任公司在第二季度增持了148.4%的Merit医疗系统股份。Lindbrook Capital LLC在此期间额外收购了285股,现在拥有这家医疗器械供应商477股股票,价值2.6万美元。Harel Insurance Investments&Financial Services Ltd.在第二季度购买了价值3.7万美元的Merit Medical Systems新股。Quantbot Technologies LP在第一季度收购了Merit医疗系统公司的一个新头寸,价值4.3万美元。First Horizon Advisors Inc.在第二季度将其在Merit Medical Systems的头寸提高了56.2%。First Horizon Advisors Inc.现在持有这家医疗器械供应商1,287股股票,价值7万美元,在此期间又购买了463股。最后,Eagle Bay Advisors LLC在第二季度将其在Merit Medical Systems的持股增加了87.0%。Eagle Bay Advisors LLC现在拥有这家医疗器械供应商1,870股股票,价值101,000美元,上个季度又购买了870股。机构投资者和对冲基金持有该公司95.38%的股票。

Get
到达
Merit Medical Systems
优点医疗系统
alerts:
警报:

Merit Medical Systems Price Performance

优点医疗系统性价比

Shares of MMSI opened at $70.62 on Monday. The company has a current ratio of 2.35, a quick ratio of 1.19 and a debt-to-equity ratio of 0.19. The firm has a market cap of $4.02 billion, a price-to-earnings ratio of 65.39, a PEG ratio of 2.50 and a beta of 1.01. Merit Medical Systems, Inc. has a 52 week low of $50.46 and a 52 week high of $76.14. The stock has a 50 day moving average of $69.67 and a 200-day moving average of $61.48.

周一,MMSI的股价开盘报70.62美元。该公司的流动比率为2.35,速动比率为1.19,债务权益比率为0.19。该公司市值为40.2亿美元,市盈率为65.39倍,聚乙二醇率为2.50倍,贝塔系数为1.01。Merge Medical Systems,Inc.的52周低点为50.46美元,52周高点为76.14美元。该股的50日移动均线切入位在69.67美元,200日移动均线切入位在61.48美元。

Merit Medical Systems (NASDAQ:MMSI – Get Rating) last released its earnings results on Wednesday, October 26th. The medical instruments supplier reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.11. Merit Medical Systems had a net margin of 5.43% and a return on equity of 14.14%. The firm had revenue of $287.18 million during the quarter, compared to analyst estimates of $273.03 million. As a group, analysts forecast that Merit Medical Systems, Inc. will post 2.57 EPS for the current year.
优点医疗系统公司(纳斯达克代码:MMSI-GET Rating)最近一次公布财报是在10月26日星期三。这家医疗器械供应商公布本季度每股收益为0.64美元,比普遍预期的0.53美元高出0.11美元。优点医疗系统公司的净利润率为5.43%,股本回报率为14.14%。该公司本季度营收为2.8718亿美元,而分析师预期为2.7303亿美元。分析师预测,作为一个整体,Merit Medical Systems,Inc.本年度每股收益将达到2.57美元。

Analyst Upgrades and Downgrades

分析师升级和下调评级

A number of equities analysts have weighed in on the company. Raymond James upped their price target on Merit Medical Systems from $71.00 to $72.00 and gave the stock an "outperform" rating in a report on Thursday, October 27th. Piper Sandler upped their price objective on shares of Merit Medical Systems from $70.00 to $73.00 in a research report on Thursday, October 27th. Canaccord Genuity Group cut Merit Medical Systems from a "buy" rating to a "hold" rating and cut their price target for the stock from $73.00 to $72.00 in a research note on Tuesday, December 20th. StockNews.com lowered Merit Medical Systems from a "strong-buy" rating to a "buy" rating in a research note on Monday, December 26th. Finally, Canaccord Genuity Group increased their target price on Merit Medical Systems from $69.00 to $73.00 in a research note on Monday, November 7th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $73.50.

许多股票分析师对该公司进行了分析。雷蒙德·詹姆斯在10月27日周四的一份报告中将Merit Medical Systems的目标价从71.00美元上调至72.00美元,并给予该股“跑赢大盘”的评级。在10月27日星期四的一份研究报告中,派珀·桑德勒将Merit医疗系统公司的股票目标价从70.00美元上调至73.00美元。在12月20日星期二的一份研究报告中,Canaccel Genuity Group将Merit Medical Systems的评级从“买入”下调至“持有”,并将该股的目标价从73.00美元下调至72.00美元。在12月26日星期一的一份研究报告中,StockNews.com将Merit Medical Systems的评级从“强力买入”下调至“买入”。最后,Canaccel Genuity Group在11月7日星期一的一份研究报告中将Merit Medical Systems的目标价从69.00美元上调至73.00美元。一位股票研究分析师将该股评级为持有,五位分析师给予该股买入评级。根据MarketBeat.com的数据,该公司的平均评级为“适度买入”,共识目标价为73.50美元。

Merit Medical Systems Company Profile

优点医疗系统公司简介

(Get Rating)

(获取评级)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.

优点医疗系统公司设计、开发、制造和营销用于介入、诊断和治疗程序的一次性医疗产品,主要用于心脏病学、放射学、肿瘤学、危重护理和内窥镜检查。该公司在心血管和内窥镜两个领域开展业务。

Featured Articles

专题文章

  • Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
  • MarketBeat: Week in Review 12/26 – 12/30
  • The Dogs Of Tech: It's Time For A Bite Of These Stocks
  • Does This Acquisition Make Microsoft a Bear Market Buy?
  • Should You Warm up to Generac Stock for the Winter?
  • Is Kintara Therapeutics A Hidden Gem?
  • 免费获取StockNews.com关于Merit Medical Systems(MMSI)的研究报告
  • MarketBeat:回顾一周12/26-12/30
  • 科技狗:是时候咬一口这些股票了
  • 这笔收购会让微软成为熊市买入者吗?
  • 你应该热身到Generac股票过冬吗?
  • 金塔拉治疗公司是一颗隐藏的宝石吗?

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating).

想看看还有哪些对冲基金持有MMSI吗?访问HoldingsChannel.com获取Merit Medical Systems,Inc.(纳斯达克代码:MMSI-GET Rating)的最新13F备案文件和内幕交易信息。

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

接受新闻和评级的优点医疗系统每日-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Merit Medical Systems和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发